![Matthew Corey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Matthew Corey
Directeur Financier/CFO chez
PIONEER MERGER CORP.
Profil
Matthew Corey is currently a Director at EdenRoc Sciences LLC, Life Biosciences, Inc., Immetas Therapeutics, Inc., and Iduna Therapeutics, Inc. He is also the Chief Financial Officer at Alpha Wave Global (Venture Capital), Pioneer Merger Corp., and Frontier Acquisition Corp.
Previously, he worked as a Director at Alterity Therapeutics Ltd. and as CFO, Senior Accountant & Controller at Gruss Capital Management LP.
He also worked as an Auditor at Rothstein Kass LLP from 2006 to 2009.
Corey received his undergraduate degree from Lehigh University and his graduate degree from Seton Hall University School of Law.
Postes actifs de Matthew Corey
| Sociétés | Poste | Début |
|---|---|---|
| PIONEER MERGER CORP. | Directeur Financier/CFO | - |
| FRONTIER ACQUISITION CORP. | Directeur Financier/CFO | - |
Alpha Wave Global (Venture Capital)
 Alpha Wave Global (Venture Capital) Investment ManagersFinance Alpha Wave Global invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage transactions. | Directeur Financier/CFO | 01/04/2019 |
Life Biosciences, Inc.
 Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures laboratory instruments and instrumentation systems | Directeur/Membre du Conseil | - |
Iduna Therapeutics, Inc. | Directeur/Membre du Conseil | - |
EdenRoc Sciences LLC
 EdenRoc Sciences LLC BiotechnologyHealth Technology Operates biotechnology company | Directeur/Membre du Conseil | - |
Immetas Therapeutics, Inc.
 Immetas Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Matthew Corey
| Sociétés | Poste | Fin |
|---|---|---|
Rothstein Kass LLP | Corporate Officer/Principal | 01/01/2009 |
| ALTERITY THERAPEUTICS LIMITED | Directeur/Membre du Conseil | - |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | - |
Formation de Matthew Corey
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
44
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Gruss Capital Management LP
 Gruss Capital Management LP Investment ManagersFinance Gruss Capital Management seeks to achieve absolute returns while preserving investor capital by investing opportunistically in global markets using a combination of event-driven investment strategies. The firm utilizes investments in equities, bonds, loans, options, credit default swaps and other instruments. They seek to manage risk by utilizing adequate diversification and liquidity while attempting to hedge unwanted market risk by employing credit default swaps, out-of-the-money options, futures, ETFs and other instruments. | Finance |
Alterity Therapeutics Ltd.
 Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University School of Law
 Seton Hall University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EdenRoc Sciences LLC
EdenRoc Sciences LLC BiotechnologyHealth Technology Operates biotechnology company | Health Technology |
Alpha Wave Global (Venture Capital)
Alpha Wave Global (Venture Capital) Investment ManagersFinance Alpha Wave Global invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for growth stage transactions. | Finance |
Rothstein Kass LLP | |
Life Biosciences, Inc.
Life Biosciences, Inc. Electronic Equipment/InstrumentsElectronic Technology Manufactures laboratory instruments and instrumentation systems | Electronic Technology |
Immetas Therapeutics, Inc.
Immetas Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapeutics that modulates the innate immune system to treat age-related cancers and inflammatory diseases | Health Technology |
Pioneer Merger Corp.
 Pioneer Merger Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Frontier Acquisition Corp.
 Frontier Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Iduna Therapeutics, Inc. |
